Neurotech International Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive NTI News and Ratings via Email

Sign-up to receive the latest news and ratings for Neurotech International and its competitors with MarketBeat's FREE daily newsletter.

About Neurotech International

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism, a portable electroencephalographic medical device that uses neuro feedback to relax the minds of children with autism spectrum disorder. The company focuses on developing neuro-stimulation and neuro-diagnostic solutions that enable medical practitioners to monitor and play an active role in home-based therapies. It also engages in executing of medical research projects; and developing of technological devices and other solutions for the screening and treatment of neurological disorders. The company was incorporated in 2016 and is based in Nedlands, Australia.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Neurotech International (ASX:NTI) Frequently Asked Questions

What stocks does MarketBeat like better than Neurotech International?

Wall Street analysts have given Neurotech International a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Neurotech International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Neurotech International's key executives?

Neurotech International's management team includes the following people:
  • Mr. Peter James Lawrence Griffiths B.Sc., Chief Exec. Officer (Age 57, Pay $282.17k)
  • Dr. Emanuela Russo, Chief Scientific Officer & Member of Scientific Advisory Board
  • Ms. Erlyn Saromines Dale A.C.I.S., B.Com., BCom., GradDipACG, AGIA, ACIS, Company Sec.

What is Neurotech International's stock symbol?

Neurotech International trades on the ASX under the ticker symbol "NTI."

How much money does Neurotech International make?

Neurotech International has a market capitalization of $0.00 and generates $225,536.00 in revenue each year.

What is Neurotech International's official website?

The official website for Neurotech International is

How can I contact Neurotech International?

The company can be reached via phone at 61 8 9389 3130.

This page was last updated on 9/24/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.